Israel Englander Repare Therapeutics Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 249,475 shares of RPTX stock, worth $878,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares

249,475

Previous 168,865 47.74%

Holding current value

$878,152

Previous $795,000 3.52%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.02 - $4.7 $243,442 - $378,867	80,610 Added 47.74%	249,475 $823,000
Q1 2024 May 15, 2024	SELL	$4.53 - $8.41 $59,940 - $111,281	-13,232 Reduced 7.27%	168,865 $795,000
Q4 2023 Feb 14, 2024	BUY	$3.22 - $11.79 $170,495 - $624,268	52,949 Added 41.0%	182,097 $1.33 Million
Q2 2023 Aug 14, 2023	SELL	$8.63 - $12.53 $2.6 Million - $3.77 Million	-300,722 Reduced 69.96%	129,148 $1.37 Million
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $1.63 Million - $2.64 Million	-175,417 Reduced 28.98%	429,870 $4.23 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $18.13 $4.47 Million - $6.49 Million	357,966 Added 144.74%	605,287 $8.9 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $1.89 Million - $2.54 Million	163,126 Added 193.75%	247,321 $3 Million
Q2 2022 Aug 15, 2022	SELL	$8.45 - $14.84 $1.15 Million - $2.02 Million	-135,959 Reduced 61.76%	84,195 $1.18 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $1.26 Million - $2.42 Million	-110,672 Reduced 33.45%	220,154 $3.14 Million
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $3.13 Million - $4.48 Million	159,365 Added 92.95%	330,826 $6.98 Million
Q3 2021 Nov 15, 2021	BUY	$25.71 - $35.24 $3.83 Million - $5.25 Million	148,876 Added 659.18%	171,461 $4.5 Million
Q2 2021 Aug 16, 2021	BUY	$30.1 - $34.85 $679,808 - $787,087	22,585 New	22,585 $704,000
Q1 2021 May 17, 2021	SELL	$25.89 - $44.46 $2.46 Million - $4.22 Million	-95,018 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.42 - $39.5 $2.22 Million - $3.74 Million	-94,627 Reduced 49.9%	95,018 $3.26 Million
Q3 2020 Nov 16, 2020	SELL	$21.55 - $33.92 $724,058 - $1.14 Million	-33,599 Reduced 15.05%	189,645 $5.84 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $6.88 Million - $7.36 Million	223,244 New	223,244 $6.93 Million

Others Institutions Holding RPTX

# of Institutions

Shares Held

36.8M

Call Options Held

51.7K

Put Options Held

17.7K

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $148M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account